Laboratory & Diagnostics

SARASOTA – November 10, 2026 -- World Precision Instruments (WPI) has launched EVOM Auto ElectroZ, which extends its automated transepithelial/endothelial electrical resistance (TEER) platform with electrochemical impedance spectroscopy (EIS) across frequencies from 2 Hz to 100 kHz. The system is available now.

ElectroZ measures impedance from 2 Hz to 100 kHz in under 20 seconds

Conventional TEER measures resistance across a cell layer at a single frequency of 12.5 Hz. ElectroZ captures both resistive and capacitive properties of living cells in a measurement that often takes less than 20 seconds.

The software automatically calculates four parameters:

OSLO, Norway – November 09, 2026 -- Photocure ASA (OSE: PHO) said the Medicare coverage timeline for its AssureMDx bladder cancer test remains in line with its original acquisition assumptions, after the test was left out of a newly published Novitas Local Coverage Determination (LCD) dated November 6, 2026. Pricing talks, however, point to a potential reimbursement level "meaningfully above" the assumptions in the company's initial underwriting.

Photocure planned for 2028 Medicare coverage when it bought Vesica Health

When Photocure acquired Vesica Health on June 4, 2026, its planning assumption was Medicare coverage in 2028, following submission of additional clinical evidence. A proposed Novitas LCD in May 2026 had raised the prospect of an earlier decision. The final LCD covers urine-based biomarkers in patients with microhematuria but does not include AssureMDx. It identifies additional clinical evidence needed for future reconsideration.

Delray Beach – November 06, 2026 -- The global high-performance liquid chromatography (HPLC) market is projected to grow from USD 7.86 billion in 2026 to USD 12.2 billion by 2031, a compound annual growth rate of 9.3%, according to MarketsandMarkets.

North America and pharma customers anchor 2025 demand

North America held the largest regional share in 2025 at 45%. Pharmaceutical and biopharmaceutical companies were also the largest end-user group at 45%. They use HPLC for drug development, purity assessment, release testing and stability monitoring.

Demand is also supported by impurity profiling, food analysis and environmental testing. Advances in UHPLC separation, automated method development and sensitive detection let laboratories handle complex samples and improve workflow efficiency.

Ipswich – November 06, 2026 -- New England Biolabs (NEB) will present an integrated cfDNA and cfRNA workflow, an enzymatic DNA methylation method and a new high-fidelity PCR master mix at the Association for Molecular Pathology (AMP) Annual Meeting & Expo, held November 10-15, 2026, at the Seattle Convention Center.

NEB workshop combines Monarch purification with NEBNext library prep for multiomic profiling

The corporate workshop, "One Sample, Many Insights: Multiomic Profiling in cfDNA and cfRNA Samples," runs Wednesday, November 11, at 10:00 AM in Tahoma 3, Level 3. It pairs Monarch Nucleic Acid Purification with NEBNext NGS Library Preparation. The workflow covers extraction through sequencing, and NEB says it is designed to recover mutation, methylation and gene-expression signals from limited samples.

SALT LAKE CITY – November 05, 2026 -- Co-Diagnostics, Inc. (Nasdaq: CODX) will release its third quarter 2026 financial results on Tuesday, November 10, after the market close, two days ahead of the previously announced date of Thursday, November 12.

Co-Diagnostics schedules a 4:30 p.m. ET call on the new date

The molecular diagnostics company will host a conference call and webcast at 4:30 p.m. ET on November 10 to discuss the results. Investors can join the webcast through the Events & Webcasts page of the company's investor relations site or dial in by toll-free or toll number. A recording will be posted on the company's website for those who cannot attend live.

PROVIDENCE – November 05, 2026 -- Electronic Genome Mapping (EGM) detected every abnormality identified by standard cytogenetic testing in an initial study, according to researchers from Augusta University and The University of Texas MD Anderson Cancer Center. They will present the findings at the Association for Molecular Pathology (AMP) 2026 Annual Meeting, November 10-14 in Seattle, Nabsys 2.0, LLC said.

Augusta and MD Anderson pathologists present EGM data on November 13

Ravindra Kolhe, M.D., Ph.D., Professor and Chair of Pathology at Augusta University, and Rashmi Kanagal-Shamanna, M.D., Professor of Hematopathology and Molecular Diagnostics at MD Anderson, will present at the Innovation Spotlight Session (stage 1). The slot runs 9:30-10:00 a.m. PT on Friday, November 13. The talk is titled "Electronic Genome Mapping for Structural Variant Detection: Implications for Advancing Clinical Research in Heme Malignancies."

ALLENTOWN – November 03, 2026 -- JULABO USA Chief Financial Officer Sam Wolf has been selected as a 2026 Leaders in Business & Finance honoree by Lehigh Valley Business in the Chief Financial Officer/VP of Finance category, months after the company reported its highest-performing quarter to date.

Wolf took the CFO role in May 2026 and helped deliver the company's best quarter

Wolf was promoted to CFO in May 2026. Since then, he has played a key role in JULABO USA's financial performance and long-term growth, including the highest-performing quarter in the company's history, according to the announcement. He joined JULABO USA during the economic uncertainty of the COVID-19 pandemic.

Milford, Mass. – November 03, 2026 -- Waters Corporation raised every component of its full-year 2026 guidance after third-quarter revenue of $1.767 billion beat the guidance midpoint by $14 million and adjusted EPS rose 21% to $4.10. The company lifted its total reported revenue outlook by $43 million at the midpoint.

Organic revenue climbs 9% as acquired businesses add $896 million

Organic revenue reached $871 million, up from $800 million a year earlier. That is 9% growth as reported and 10% in constant currency. The acquired Biosciences and Diagnostic Solutions businesses contributed $896 million, compared with $885 million on a prior-year comparable basis.

GAAP diluted EPS fell to $0.82 from $2.50 a year earlier. Waters attributed the drop to acquisition-related purchase accounting charges, acquisition-related costs and restructuring costs. Adjusted EPS rose from $3.40 to $4.10.

Westborough, Mass. – October 29, 2026 -- KPM Analytics has released UCAL 5, a near-infrared (NIR) calibration platform for SpectraStar XT Series analyzers that checks every calibration against ASTM E1655 and ISO 12099 recommendations as the user works. The patent-pending guided workflow takes users from KPM calibration libraries to a published calibration for their own products in four steps. A 30-day free trial of UCAL 5 Pro is available now to current SpectraStar XT users.

UCAL Insight flags weak calibrations with green, yellow and red marks

UCAL Insight checks whether a calibration has enough samples, how well laboratory values cover the required range, and whether new samples confirm the calibration. Each point is marked green, yellow or red with an explanation. The marks are suggestions, and the user makes the final decision.

Wilmington – October 29, 2026 -- LabWare and Phizzle have made LabWare Loop available by request to LabWare customers, with commercial availability planned for early 2027. The vendor-agnostic tool moves results from legacy and modern instruments directly into LabWare sample result records, replacing manual data handling with a verified chain of custody.

The workflow follows each GxP sample from sampling plan to result in a single auditable digital process. It supports 21 CFR Part 11, EU Annex 11 and ALCOA+ data integrity principles.